The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Female

This is a "connection" page, showing publications Kenneth S. Cohen has written about Female.
Connection Strength

0.538
  1. Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs. JAMA Netw Open. 2022 12 01; 5(12):e2246064.
    View in: PubMed
    Score: 0.041
  2. An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity. J Neurooncol. 2021 May; 152(3):567-572.
    View in: PubMed
    Score: 0.036
  3. Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors. Atherosclerosis. 2013 Jul; 229(1):228-33.
    View in: PubMed
    Score: 0.021
  4. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
    View in: PubMed
    Score: 0.021
  5. Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood. 2013 Feb 21; 121(8):e50-6.
    View in: PubMed
    Score: 0.021
  6. Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant? Leuk Lymphoma. 2011 Jul; 52(7):1173-5.
    View in: PubMed
    Score: 0.018
  7. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
    View in: PubMed
    Score: 0.018
  8. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol. 2011 Apr; 13(4):410-6.
    View in: PubMed
    Score: 0.018
  9. Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2009 Dec; 148(6):895-901.e1.
    View in: PubMed
    Score: 0.016
  10. At the canyon's edge: depression in American Indian culture. Explore (NY). 2008 Mar-Apr; 4(2):127-35.
    View in: PubMed
    Score: 0.015
  11. Retinal thickness measurement after phacoemulsification. J Cataract Refract Surg. 2004 Jul; 30(7):1501-6.
    View in: PubMed
    Score: 0.011
  12. Familial, band-shaped, spheroidal keratopathy histopathology in ethnic Chinese siblings. Cornea. 2002 Nov; 21(8):774-7.
    View in: PubMed
    Score: 0.010
  13. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610.
    View in: PubMed
    Score: 0.010
  14. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 09 01; 140(3):477-487.
    View in: PubMed
    Score: 0.010
  15. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
    View in: PubMed
    Score: 0.009
  16. Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg. 2000 Jan; 32(1):24-9.
    View in: PubMed
    Score: 0.008
  17. Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
    View in: PubMed
    Score: 0.008
  18. A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors. Clin Cancer Res. 2019 12 15; 25(24):7294-7302.
    View in: PubMed
    Score: 0.008
  19. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
    View in: PubMed
    Score: 0.008
  20. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555.
    View in: PubMed
    Score: 0.008
  21. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
    View in: PubMed
    Score: 0.007
  22. Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1234-1242.
    View in: PubMed
    Score: 0.007
  23. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
    View in: PubMed
    Score: 0.007
  24. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.007
  25. University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. Br J Haematol. 2018 04; 181(2):264-267.
    View in: PubMed
    Score: 0.007
  26. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus. J Clin Rheumatol. 2016 Sep; 22(6):320-3.
    View in: PubMed
    Score: 0.007
  27. A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017 Jan 01; 123(1):161-168.
    View in: PubMed
    Score: 0.007
  28. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
    View in: PubMed
    Score: 0.006
  29. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.
    View in: PubMed
    Score: 0.006
  30. Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas. Eur J Radiol. 2016 Apr; 85(4):700-6.
    View in: PubMed
    Score: 0.006
  31. Identifying early dropouts from a rehabilitation program for psychiatric outpatients. Psychiatr Serv. 1995 Oct; 46(10):1076-8.
    View in: PubMed
    Score: 0.006
  32. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.
    View in: PubMed
    Score: 0.006
  33. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
    View in: PubMed
    Score: 0.006
  34. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
    View in: PubMed
    Score: 0.006
  35. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014 Nov 07; 35(42):2972-9.
    View in: PubMed
    Score: 0.006
  36. Response to Passos et al. Pediatr Neurol. 2014 Feb; 50(2):e3-4.
    View in: PubMed
    Score: 0.005
  37. Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer. 2013 Dec; 60(12):2036-41.
    View in: PubMed
    Score: 0.005
  38. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013 Oct; 49(4):237-42.
    View in: PubMed
    Score: 0.005
  39. Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1307-11.
    View in: PubMed
    Score: 0.005
  40. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
    View in: PubMed
    Score: 0.005
  41. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol. 2012 Nov; 124(5):627-41.
    View in: PubMed
    Score: 0.005
  42. Circulating angiogenic cell populations, vascular function, and arterial stiffness. Atherosclerosis. 2012 Jan; 220(1):145-50.
    View in: PubMed
    Score: 0.005
  43. Magnetic resonance imaging features of meningiomas in children and young adults: a retrospective analysis. J Neuroradiol. 2012 Oct; 39(4):218-26.
    View in: PubMed
    Score: 0.005
  44. OCT-documented incision features and natural history of clear corneal incisions used for bimanual microincision cataract surgery. Cornea. 2011 Jun; 30(6):681-6.
    View in: PubMed
    Score: 0.005
  45. Genetic and clinical correlates of early-outgrowth colony-forming units. Circ Cardiovasc Genet. 2011 Jun; 4(3):296-304.
    View in: PubMed
    Score: 0.005
  46. T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse. Leuk Lymphoma. 2011 Feb; 52(2):214-22.
    View in: PubMed
    Score: 0.004
  47. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol. 2010 Dec; 34(12):1783-91.
    View in: PubMed
    Score: 0.004
  48. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation. 2010 Sep 21; 122(12):1176-82.
    View in: PubMed
    Score: 0.004
  49. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol. 2010 Sep; 99(2):155-63.
    View in: PubMed
    Score: 0.004
  50. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
    View in: PubMed
    Score: 0.004
  51. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug; 99(1):65-71.
    View in: PubMed
    Score: 0.004
  52. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders. Subst Abus. 2009 Jan-Mar; 30(1):40-6.
    View in: PubMed
    Score: 0.004
  53. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34):12469-73.
    View in: PubMed
    Score: 0.004
  54. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008 Aug; 51(2):245-50.
    View in: PubMed
    Score: 0.004
  55. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
    View in: PubMed
    Score: 0.004
  56. Determining factors for corneal endothelial cell loss by using bimanual microincision phacoemulsification and power modulation. Cornea. 2007 Oct; 26(9):1049-55.
    View in: PubMed
    Score: 0.004
  57. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol. 2007 May; 4(5):316-21.
    View in: PubMed
    Score: 0.003
  58. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg. 2006 May; 32(5):803-11.
    View in: PubMed
    Score: 0.003
  59. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006 Feb; 23(2):99-107.
    View in: PubMed
    Score: 0.003
  60. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood. 2006 Apr 01; 107(7):2774-6.
    View in: PubMed
    Score: 0.003
  61. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol. 2005 Nov 01; 23(31):8136-9.
    View in: PubMed
    Score: 0.003
  62. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004 May; 63(5):441-9.
    View in: PubMed
    Score: 0.003
  63. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
    View in: PubMed
    Score: 0.003
  64. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol. 2002 Jan; 12(1):36-44.
    View in: PubMed
    Score: 0.002
  65. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
    View in: PubMed
    Score: 0.002
  66. Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol. 2000 Jul-Aug; 3(4):346-52.
    View in: PubMed
    Score: 0.002
  67. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.